United States Biomaterial Wound Dressings Market is Expected to Dominate By Alginate Dressing Through 2028
During the forecast period, 2024–2028,
growing incidences of chronic wounds is anticipated to fuel the expansion of
United States biomaterial wound dressings market.
According to TechSci
Research report, “United States
Biomaterial Wound Dressings -
By Region, Forecast and Opportunities, 2018-2028”, The United States biomaterial wound dressings market has
witnessed substantial growth over the years, owing to the rising incidence of
burns, surgical wounds, and chronic wounds. As a result, there is a growing
demand for advanced wound care products such as biomaterial dressings.
The ageing population
in the United States is a significant market factor for biomaterial wound
dressings. Chronic disorders including diabetes and cardiovascular disease,
which are linked to an increased incidence of chronic wounds, are increasing as
the population ages. As a result, it is anticipated that in the years to come,
demand for advanced wound care products, such as biomaterial wound dressings,
will rise.
Further to these
factors, a number of developments are influencing the market for biomaterial
wound dressings. The application of regenerative therapies in wound care is one
of these trends. To encourage tissue regeneration and healing, regenerative
medicine makes use of biomaterials, cells, and other biological components. An
essential component of regenerative medicine, biomaterial wound dressings are
used to treat various kinds of wounds, including venous leg ulcers and diabetic
foot ulcers.
To promote tissue
regeneration, researchers have been looking at utilising nanotechnology to
create wound dressings that may release drugs or hormones that promote growth.
Researchers are also conducting research on biomaterials that may imitate the
structure and functioning of natural tissues like cartilage and skin.
The market for
biomaterial wound dressings in the United States has been significantly
impacted by the COVID-19 pandemic. Objectives in healthcare have shifted
because of the pandemic, with an increased emphasis on infection prevention and
control. The application of biomaterial wound dressings has been impacted since
healthcare professionals are now emphasizing the use of antimicrobial
dressings, which can help reduce the risk of infection. The pandemic has caused
supply chain problems, which have caused shortage of a variety of biomaterial
wound dressings. With a greater dependence on telemedicine and remote monitoring,
the pandemic additionally altered the way healthcare is provided.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on “United States Biomaterial Wound Dressings Market”
The United States
Biomaterial Wound Dressings Market can be segmented by product, type application,
end user, and region.
Based on product,
the market can be segmented into alginate dressing, hydrocolloids, skin
substitutes, and others. Due to their unique characteristics and benefits
alginate dressings are expected to dominate and occupy up the largest
share of the biomaterial wound dressing market in the United States in the
upcoming years. Alginate dressings originate from natural seaweed and have
great absorbing qualities, making them extremely useful in controlling moderate
to heavily leaking wounds. They additionally develop on a gel-like consistency
when in contact with wound exudate, which encourages moist wound healing and
lessens risk of tissue injury. Alginate dressings are also biodegradable, which
makes them a popular choice for patients and healthcare professionals seeking
environmentally responsible wound care procedures. Alginate dressings are
anticipated to continue developing pace and take the forefront in the market
for biomaterial wound dressings as focus shifts more and more to innovative
wound care solutions.
In terms of type,
the market can be divided into primary and secondary. Due to their vital
function in handling wound care, primary dressings are expected to dominate and
obtain the highest share of the biomaterial wound dressing market in the United
States in the years to come. Primary dressings are made to directly contact the
wound bed and act as a barrier to prevent further harm or infection. To control
wound exudate and encourage healing, they are frequently used in conjunction
with secondary dressings. Primary dressings with antimicrobial qualities are
expected to grow in popularity in the years to come as the importance of
infection prevention and control increases, spurring market expansion. Primary
dressings are expected to maintain their dominance and gain the highest
proportion of the biomaterial wound dressing market due to its necessity in the
management of wounds.
Based on the end
user, the market can be classified into the following categories, hospitals
& clinics, ambulatory surgical centers (ASC), and homecare. Due to their
huge number of patients and an increasing demand for advanced wound care
products, hospitals and clinics are expected to dominate and take the largest
percentage of the biomaterial wound dressing market in the United States in
the coming years. As a result of the ageing population and the increasing
incidence of chronic wounds, hospitals and clinics are the primary centers for
managing wound care, which is propelling market expansion. The COVID-19
pandemic has raised the need for advanced wound care products in hospitals and
clinics. This is because infection prevention and control measures in
healthcare settings are now even more necessary.
Major companies
operating in United States Biomaterial Wound Dressings Market include:
- 3M Company
- Johnson & Johnson
- Mölnlycke Health Care AB
- Integra Lifesciences Corporation
- ConvaTec Group Plc
- Coloplast A/S
- Hartmann USA
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Technological advancements, a
surge in clinical trials, and an increase in the prevalence of diabetic ulcers
are few factors contributing to the substantial growth of the biomaterial wound
dressing market in the United States. The efficacy of biomaterial wound dressings
in aiding wound healing and reducing infection has been established through
recent clinical trials, leading to an increase in their use in healthcare
environments. As a result of technological advancement, innovative wound
dressings with enhanced healing capabilities, like alginate and hydrogel
dressings, have been developed. The frequency of chronic wounds is mostly
caused by diabetic ulcers, which is fueling market expansion. The market for
biomaterial wound dressings is anticipated to grow more in coming years in
the United States due to an ageing population and an increase in the prevalence
of chronic diseases.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based global management consulting firm.
“United
States Biomaterial Wound Dressings Market, By Product (Alginate Dressing,
Hydrocolloids, Skin Substitutes, and Others), By Type (Primary, Secondary), By
Application (Wounds, Burns, Ulcers, and Others), By End Users (Hospitals &
Clinics, Ambulatory Surgical Centers (ASC), and Homecare), By Region,
Competition, Forecast and& Opportunities, 2028”, has evaluated the future
growth potential of United States biomaterial wound dressings market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United States biomaterial wound dressings
market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com